Quoin Pharmaceuticals (QNRX)
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare an...
- Open
- 7.640
- High
- 7.687
- Low
- 7.100
- Prev. Close
- 7.870
- Volume
- 79.05K
- Turnover
- 579.84K
- Avg Price
- 7.335
- Bid/Ask Ratio
- --
- Amplitude
- 7.46%
- 52wk High
- 41.800
- Volume Ratio
- 10.55
- Turnover Ratio
- 6.67%
Quoin Pharmaceuticals Analyst Rating
View moreForecast & Rating
Sep 2, 2026Price forecast
$22.20205.79%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 2 days ago, 01:38 AM
Quoin Pharmaceuticals director Anthony James Culverwell acquires shares worth $29,988.48
- Price Alert · Sep 1 at 12:46 AM
U.S. stock night market fluctuations: QNRX fell 4.98% in night trading: no significant negative news, high volatility due to capital speculation
- Price Alert · Aug 31 at 12:22 AM
U.S. stock night trading opened with fluctuations: Modular Medical rose 8.38% in night trading; Quoin Pharmaceuticals fell 6.86% in night trading
- US Stock Market Update · Aug 28 at 07:19 PM
Quoin Pharmaceuticals soars 25% on broad healthcare strength
- US Stock Market Update · Aug 28 at 06:01 PM
Quoin Pharmaceuticals surges 29% during regular trading as healthcare sector rallies
- benzinga_article · Aug 28 at 05:05 PM
12 Health Care Stocks Moving In Friday's Intraday Session
